BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31995625)

  • 1. Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients.
    Pellegrino M; Traversi G; Arena A; Cappa M; Rosado MM; Andreani M; Delfino DV; Moretti F; Fierabracci A
    PLoS One; 2020; 15(1):e0228296. PubMed ID: 31995625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With Thyroid Cancer and Autoimmunity.
    Arena A; Stigliano A; Belcastro E; Giorda E; Rosado MM; Grossi A; Assenza MR; Moretti F; Fierabracci A
    Front Immunol; 2021; 12():728381. PubMed ID: 34539667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-inflammation characterized by disturbed Treg/Teff balance with increasing sIL-2R in patients with type 2 diabetes.
    Cai B; Zhang J; Zhang M; Li L; Feng W; An Z; Wang L
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):214-9. PubMed ID: 23595796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific differences in T-cell immune dysregulation and aberrant response to inflammatory stimuli in offspring exposed to maternal chronic inflammation.
    Liu J; Liu Y; Kirschen G; Liu A; Lei J; Burd I
    Am J Reprod Immunol; 2023 Mar; 89(3):e13665. PubMed ID: 36504421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory/effector T-cell ratio is reduced in coronary artery disease.
    Emoto T; Sasaki N; Yamashita T; Kasahara K; Yodoi K; Sasaki Y; Matsumoto T; Mizoguchi T; Hirata K
    Circ J; 2014; 78(12):2935-41. PubMed ID: 25327882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels.
    Maes M; Nani JV; Noto C; Rizzo L; Hayashi MAF; Brietzke E
    Mol Neurobiol; 2021 Jan; 58(1):229-242. PubMed ID: 32914395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual Effector/Regulator T Cell Ratios Impact Bone Regeneration.
    Schlundt C; Reinke S; Geissler S; Bucher CH; Giannini C; Märdian S; Dahne M; Kleber C; Samans B; Baron U; Duda GN; Volk HD; Schmidt-Bleek K
    Front Immunol; 2019; 10():1954. PubMed ID: 31475013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects of HIV-1 gp41 fusion peptide on CD3 antibody activated regulatory T cells].
    He LG; Hu YP; Peng H; Li MM; Liu SW; Li XJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1121-5. PubMed ID: 23127396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Sustained Resistance to Suppression of CD8+ Teff Cells at the Site of Autoimmune Inflammation Can Be Reversed by Tumor Necrosis Factor and Interferon-γ Blockade.
    Petrelli A; Wehrens EJ; Scholman RC; Prakken BJ; Vastert SJ; van Wijk F
    Arthritis Rheumatol; 2016 Jan; 68(1):229-36. PubMed ID: 26360332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
    Åkesson K; Tompa A; Rydén A; Faresjö M
    Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Percentage of CD8
    Houston TW; Howlett-Prieto Q; Regenauer C; Testai FD; Yao F; Feng X; Reder AT
    Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36535763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
    Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
    Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
    Schneider A; Rieck M; Sanda S; Pihoker C; Greenbaum C; Buckner JH
    J Immunol; 2008 Nov; 181(10):7350-5. PubMed ID: 18981158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation state.
    Schwedhelm K; Thorpe J; Murray SA; Gavin M; Speake C; Greenbaum C; Cerosaletti K; Buckner J; Long SA
    Clin Immunol; 2017 Aug; 181():67-74. PubMed ID: 28645874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.
    Pathangey LB; McCurry DB; Gendler SJ; Dominguez AL; Gorman JE; Pathangey G; Mihalik LA; Dang Y; Disis ML; Cohen PA
    Oncotarget; 2017 Feb; 8(7):10785-10808. PubMed ID: 27974697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.